Related Experiment Videos
Surgery for Rathke cleft cysts: technical considerations and outcomes
Ronald J Benveniste1, Wesley A King, Jane Walsh
1Departments of Neurosurgery and Radiology, Mount Sinai School of Medicine, New York, New York 10029-6574, USA.
Journal of Neurosurgery
|October 16, 2004
Summary
Transsphenoidal decompression and biopsy for Rathke cleft cysts (RCCs) effectively manage symptoms with low morbidity. While 16% may require reoperation, it offers durable remission, suggesting this approach is optimal.
Area of Science:
- Neurosurgery
- Endocrinology
- Ophthalmology
Background:
- Rathke cleft cysts (RCCs) are common sellar region neoplasms.
- Symptomatic RCCs can cause headaches, visual deficits, and hormonal dysfunction.
- Optimal surgical management for RCCs remains debated.
Purpose of the Study:
- To identify optimal surgical goals and techniques for managing symptomatic Rathke cleft cysts (RCCs).
Main Methods:
- Retrospective study of 62 patients undergoing surgery for RCCs.
- Transsphenoidal cyst decompression and biopsy (n=56) vs. cyst wall resection (n=6).
- Mean follow-up of 28 months.
Main Results:
- Symptomatic improvement in 91% (headaches) and 92% (visual deficits).
- Decompression/biopsy: 10% new pituitary hormone deficiencies, 6% new diabetes insipidus.
- Relapse rate was 16%; cyst wall resection trended towards decreased relapse.
- Repeated operations (11%) led to symptomatic improvement and durable remission.
Conclusions:
- Transsphenoidal decompression and biopsy offer effective symptomatic relief for RCCs with low morbidity.
- While 16% may require reoperation, subsequent surgeries provide symptomatic improvement and durable remission.
- Decompression and biopsy may represent the optimal surgical management for Rathke cleft cysts.